BackTNF Pharmaceuticals Overview

TNF Pharmaceuticals Accounts Payable

Track TNF Pharmaceuticals's accounts payable ($960K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$960308.00
↓ 55.64% YoYΔ $-1.20M vs prior year quarter

Peer trimmed avg / median

Loading

TNF Pharmaceuticals Accounts Payable History

Loading

TNF Pharmaceuticals vs. peers: Accounts Payable Comparison

Loading

TNF Pharmaceuticals Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

TNF Pharmaceuticals (TNFA) FAQ

The latest accounts payable for TNFA is $960K as of March 2026. That compares with $2.2M in the prior-year period — down 55.6% year over year. Investors often review this figure alongside TNF Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, TNFA's accounts payable moved from $2.2M to $960K — a 55.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in TNF Pharmaceuticals's operating scale or balance-sheet position.

A accounts payable figure of $960K for TNFA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting TNFA's accounts payable ($960K), review year-over-year change from $2.2M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.